American Airlines To Rally Around 42%? Here Are 10 Top Analyst Forecasts For Tuesday
Portfolio Pulse from Avi Kapoor
Wall Street analysts have updated their price targets and ratings for several US-listed companies, impacting their stock prices. Notable changes include upgrades and downgrades for companies such as Avadel Pharmaceuticals, Noble Corporation, Anheuser-Busch InBev, Sea Limited, Viant Technology, American Airlines Group, The Chemours Company, Veeva Systems, Avidity Biosciences, and Genesco Inc.
March 05, 2024 | 2:30 pm
News sentiment analysis
Sort by:
Descending
POSITIVE IMPACT
HC Wainwright & Co. raised Avadel Pharmaceuticals' price target from $21 to $25, maintaining a Buy rating. Shares gained 17.6%.
The increase in price target by HC Wainwright & Co. and the maintenance of a Buy rating likely contributed to the significant share price gain, indicating positive investor sentiment.
CONFIDENCE 85
IMPORTANCE 80
RELEVANCE 90
POSITIVE IMPACT
Needham raised Viant Technology's price target from $10 to $12, maintaining a Buy rating. Shares gained 1.3%.
The increase in Viant Technology's price target by Needham, along with a maintained Buy rating, likely contributed to the positive share price movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
POSITIVE IMPACT
JP Morgan upgraded Sea Limited from Neutral to Overweight and raised the price target from $43 to $70. Shares gained 5.6%.
The upgrade to Overweight and significant increase in price target by JP Morgan likely drove the strong positive reaction in Sea Limited's share price.
CONFIDENCE 90
IMPORTANCE 85
RELEVANCE 90
POSITIVE IMPACT
Keybanc raised Veeva Systems' price target from $232 to $250, maintaining an Overweight rating. Shares climbed 1.8%.
The increase in Veeva Systems' price target by Keybanc, along with a continued Overweight rating, likely contributed to the positive share price movement.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Bernstein raised American Airlines' price target from $20 to $21, maintaining an Outperform rating. Shares fell 5.4%.
Despite the slight increase in price target and an unchanged Outperform rating by Bernstein, American Airlines' shares experienced a significant decline, possibly due to broader market conditions.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85
NEGATIVE IMPACT
TD Cowen reduced Anheuser-Busch InBev's price target from $67 to $65, maintaining an Outperform rating. Shares fell 0.1%.
The minor adjustment in Anheuser-Busch InBev's price target by TD Cowen, with an unchanged Outperform rating, led to a slight decrease in share price.
CONFIDENCE 75
IMPORTANCE 60
RELEVANCE 70
NEGATIVE IMPACT
UBS downgraded The Chemours Company from Buy to Neutral and slashed the price target from $37 to $21. Shares fell 2.8%.
The downgrade to Neutral and significant reduction in price target by UBS likely led to the negative investor reaction and share price decline for The Chemours Company.
CONFIDENCE 85
IMPORTANCE 85
RELEVANCE 90
NEGATIVE IMPACT
B. Riley Securities downgraded Genesco from Buy to Neutral and cut the price target from $43 to $31. Shares fell 1%.
The downgrade to Neutral and reduction in price target by B. Riley Securities likely contributed to the slight decrease in Genesco's share price.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Barclays lowered Noble Corporation's price target from $61 to $59 but maintained an Overweight rating. Shares fell 0.8%.
The slight reduction in Noble Corporation's price target by Barclays, despite maintaining an Overweight rating, may have contributed to the modest share price decline.
CONFIDENCE 80
IMPORTANCE 70
RELEVANCE 80
NEGATIVE IMPACT
Chardan Capital raised Avidity Biosciences' price target from $23 to $33, maintaining a Buy rating. Shares fell 6.2%.
Despite the significant increase in price target and a maintained Buy rating by Chardan Capital, Avidity Biosciences' shares experienced a notable decline, which could be due to external market factors.
CONFIDENCE 80
IMPORTANCE 75
RELEVANCE 85